AJP - GI Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 297: G834-G839, 2009. First published July 23, 2009; doi:10.1152/ajpgi.00095.2009
0193-1857/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/4/G834    most recent
00095.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Frei, E.
Right arrow Articles by Wegener, J. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frei, E.
Right arrow Articles by Wegener, J. W.

NEUROREGULATION AND MOTILITY

Calcium-dependent and calcium-independent inhibition of contraction by cGMP/cGKI in intestinal smooth muscle

Eva Frei, Maria Huster, Petra Smital, Jens Schlossmann, Franz Hofmann, and Jörg W. Wegener

Institut für Pharmakologie und Toxikologie, Technische Universität München, Munich, Germany

Submitted March 11, 2009 ; accepted in final form July 17, 2009

cGMP-dependent protein kinase I (cGKI) induces relaxation of smooth muscle via several pathways that include inhibition of intracellular Ca2+ signaling and/or involve activation of myosin phosphatase. In the present study, we investigated these mechanisms comparatively in colon and jejunum longitudinal smooth muscle from mice. In simultaneous recordings from colon muscle, 8-bromo-cGMP (8-Br-cGMP) reduced both carbachol-induced tension and carbachol-induced increase in intracellular Ca2+ concentration ([Ca2+]i). These effects of 8-Br-cGMP were absent in colon from mice carrying a mutated inositol-1,4,5 trisphosphate receptor I-associated G kinase substrate (IRAG) gene or lacking cGKI. However, in jejunum, 8-Br-cGMP reduced carbachol-induced tension but did not change corresponding [Ca2+]i signals. This setting was also observed in jejunum from mice carrying a mutated IRAG gene, whereas no response to 8-Br-cGMP was observed in jejunum from mice lacking cGKI. After inhibition of phosphatase activity by calyculin A, 8-Br-cGMP did not relax jejunum but still relaxed colon muscle. In Western blot analysis, 8-Br-cGMP reduced the signal for phosphorylated MYPT-1 in carbachol-stimulated jejunum but not in colon. These results suggest that cGMP/cGKI signaling differentially inhibits contraction in the muscles investigated: in jejunum, inhibition is performed without changing [Ca2+]i and is dependent on phosphatase activity, whereas in colon, inhibition is mediated by inhibition of [Ca2+]i signals.

inositol-1,4,5 trisphosphate receptor I-associated G kinase substrate; myosin phosphatase targeting subunit 1; guanosine 3',5'-cyclic monophosphate-dependent protein kinase I; colon; jejunum



Address for reprint requests and other correspondence: J. W. Wegener, Institut für Pharmakologie und Toxikologie, TU München, Biedersteiner Str. 29, 80802 Munich, Germany (e-mail: wegener{at}ipt.med.tu-muenchen.de).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.